Immunic prices $5.1M registered direct offering of 5.67M shares at $0.90/share

IMMUNIC, INC.

Offering led by Aberdeen Investments; Titan Partners as placement agent.
Gross proceeds ~$5.1M; net proceeds ~$4.6M after commissions and expenses.
Shares sold at $0.90 per share under existing shelf registration statement.
Expected to close on April 10, 2025; proceeds to fund clinical trials and operations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.